Finance

Lists
HNSA:STO
Hansa Biopharma AB
SEK 46.28
0.00%
(0.00) 1D
Nov 13, 4:05:13 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
SEK 46.50
High
SEK 47.84
Low
SEK 42.74
Mkt. cap
4.71B
Avg. vol.
616.01K
Volume
1.13M
52-wk high
SEK 49.32
52-wk low
SEK 23.52
EPS
-SEK 7.90
Shares outstanding
101.76M
No. of employees
131
Open
SEK 46.50
High
SEK 47.84
Low
SEK 42.74
Mkt. cap
4.71B
Avg. vol.
616.01K
Volume
1.13M
52-wk high
SEK 49.32
52-wk low
SEK 23.52
EPS
-SEK 7.90
Shares outstanding
101.76M
No. of employees
131
News stories
From web sources and news partners
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees131
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
75.99M
34.57M
48.10M
142.99M
Cost of goods sold
24.66M
13.78M
22.33M
-
Cost of revenue
24.66M
13.78M
22.33M
-
Research and development expenses
74.43M
57.34M
67.87M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101.62M
105.56M
118.93M
-
Operating expense
176.02M
162.90M
186.83M
-
Total operating expenses
200.67M
176.68M
209.16M
-
Operating income
-124.68M
-142.11M
-161.06M
-
Other non operating income
-
1.38M
-30.53M
-
EBT including unusual items
-169.50M
-195.87M
-259.86M
-
EBT excluding unusual items
-169.50M
-195.87M
-259.86M
-
Income tax expense
396.00K
453.00K
677.00K
-
Effective tax rate
-0.23%
-0.23%
-0.26%
-
Other operating expenses
-34.00K
-
28.00K
-
Net income
-169.90M
-196.32M
-260.54M
-
Net profit margin
-223.58%
-567.89%
-541.71%
-
Earnings per share
-1.62
-1.93
-2.26
-1.63
Interest and investment income
-
2.55M
3.20M
-
Interest expense
-208.06M
-28.90M
-58.48M
-
Net interest expenses
-208.06M
-26.35M
-55.27M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-124.05M
-141.48M
-149.39M
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps